Applied Biosciences Corp.
APPB · OTC
12/31/2019 | 9/30/2019 | 6/30/2019 | 3/31/2019 | |
|---|---|---|---|---|
| Revenue | $170 | $244 | $211 | $235 |
| % Growth | -30.6% | 15.5% | -9.8% | – |
| Cost of Goods Sold | $51 | $98 | $100 | $82 |
| Gross Profit | $118 | $146 | $112 | $153 |
| % Margin | 69.7% | 59.7% | 52.8% | 65% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $997 | $707 | $444 | $380 |
| SG&A Expenses | $1,048 | $927 | $554 | $522 |
| Sales & Mktg Exp. | $51 | $220 | $110 | $142 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,088 | $967 | $593 | $562 |
| Operating Income | -$970 | -$821 | -$482 | -$409 |
| % Margin | -572.2% | -336% | -227.8% | -174.5% |
| Other Income/Exp. Net | -$456 | -$34 | -$26 | $137 |
| Pre-Tax Income | -$1,426 | -$855 | -$508 | -$272 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,353 | -$778 | -$424 | -$232 |
| % Margin | -798.1% | -318.4% | -200.5% | -98.8% |
| EPS | -0.099 | -0.058 | -0.031 | -0.016 |
| % Growth | -71.6% | -88.3% | -88.3% | – |
| EPS Diluted | -0.099 | -0.058 | -0.031 | -0.016 |
| Weighted Avg Shares Out | 13,649 | 13,466 | 13,806 | 14,208 |
| Weighted Avg Shares Out Dil | 13,649 | 13,466 | 13,806 | 14,208 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $89 | $39 | $26 | $74 |
| Depreciation & Amortization | $63 | $40 | $40 | $40 |
| EBITDA | -$1,274 | -$777 | -$442 | -$158 |
| % Margin | -751.5% | -318% | -209% | -67.5% |